Why do people with rhinitis have itchy eyes?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Why do people with rhinitis have itchy eyes?

Clinical Summary and Overview

In the realm of allergic and immune-mediated diseases, the topic Why do people with rhinitis have itchy eyes? It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Why do the eyes of people with rhinitis itch?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Why do people with rhinitis have itchy eyes?

Why do the eyes of people with allergic rhinitis itch?

A very common question among patients suffering from respiratory allergies is why itchy eyes often accompany rhinitis attacks. The explanation for this symptom lies in the rich innervation network and anatomical proximity of the upper airways. The nose has numerous nerve endings that connect and share communication pathways with the ocular region.

When a patient comes into contact with allergens, an inflammatory process is triggered in the nasal mucosa. Due to this nerve interconnection, the information and stimuli from the inflammation end up spreading to other areas of the face, reaching the eyes. This is why many patients develop what is called allergic rhinoconjunctivitis, characterized by the simultaneous inflammation of the nose and ocular structures.

A key point highlighted in the clinical practice of the Brazil Without Allergies Project is that, frequently, the eye problem does not stem from a primary allergy in the eyes, but rather from a reflection of the inflammatory process originating in the nose. In these cases, the organ that suffers directly from the allergic aggression is the nasal passage, while the eyes only receive the repercussions of this systemic and local inflammation.

For this reason, isolated treatments applied directly to the eyes—such as the use of inappropriate eye drops or without proper monitoring—often do not bring the expected improvement. If the underlying cause, which is in the nose, is not properly diagnosed and treated, the ocular symptoms will persist. To achieve effective control of rhinoconjunctivitis, a complete evaluation of the upper airways is necessary, addressing nasal inflammation.

Proper management involves the strict use of medications prescribed by a specialist physician, the adoption of effective environmental control measures to avoid contact with allergens, and, when indicated, the administration of allergen-specific immunotherapy (commonly known as allergy shots). This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized assessment with a specialist physician.

Developments in Evidence-Based Medicine: The Unified Airway Concept (ARIA/EPOS)

The international ARIA consensuses (Allergic Rhinitis and its Impact on Asthma) and EPOS (European Position Paper on Rhinosinusitis and Nasal Polyps) consolidate the pathophysiological concept of single (unified) air routeThe nasal mucosa, paranasal sinuses, and tracheobronchial tree share the same ciliated pseudostratified respiratory epithelium and the same immunological mechanisms mediated by IgE, mast cells, and eosinophils. Persistent edema of the sinus drainage ostia in uncontrolled allergic rhinitis predisposes to mucociliary stasis, post-nasal drip, recurrent rhinosinusitis, and bronchial hyperreactivity. Evidence-based management integrates nasal hygiene with isotonic/hypertonic saline solution, topical intranasal corticosteroids, environmental control, and... allergen-specific immunotherapy to induce lasting immune tolerance.

💎 Diamond Plan — Eyes and ears free from recurring allergic inflammation. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity

Inflammation of the Respiratory Mucosa, House Mites, and Local Complications

Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.

Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy

Environmental hygiene measures in the bedroom — waterproofing of mattresses and pillows, solar ventilation, and removal of dust reservoirs — go hand in hand with the allergy test and the vaccine for rhinitis individualized. When indicated by the specialist, the allergy vaccine It reduces nasal congestion in a lasting way and prevents the progression to recurrent sinusitis and bronchial hyperreactivity.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions related to why rhinitis causes itchy eyes profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, implementing a comprehensive clinical and environmental rehabilitation approach restores daily autonomy and overall well-being to the individual.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Eyes and ears free from recurrent allergic inflammation.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

It is concluded that the efficient management of issues related to Why do people with rhinitis have itchy eyes? It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: